US Stocks
/
SAB Biotherapeutics, Inc. Warrant Share Price

SAB Biotherapeutics, Inc. Warrant Share Price

NASDAQ: SABSW | Micro Cap
$0.02
+$0.02 (--%) Last updated on 06 Aug, 2026 | 00:57 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

SAB Biotherapeutics, Inc. Warrant Stock Performance

Open
$0.02
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.02 - $0.02
Year Range
$0.01 - $0.05
Volume
500
Average Traded
$0.02

SAB Biotherapeutics, Inc. Warrant Share Price Chart

$0.02$0.02
L
Show Current Price
H

SAB Biotherapeutics, Inc. Warrant Stock Fundamentals & Key Indicators

Market Cap
$328300.57
PE Ratio (TTM)
0.08
Dividend Yield
N/A
EPS (TTM)
$0.22
Revenue (TTM)
N/A
Return On Equity (TTM)
8.76%
Profit Margin
N/A
Debt to Equity
0.07
Quarterly Earnings Growth YoY
539.11%

SAB Biotherapeutics, Inc. Warrant Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$263137.00N/AN/AN/AN/A
Net Profit-$5.03M-$7.34M-$10.35M-$5.20M-$10.11M$45.45M
Net Profit MarginN/A-2787.69%N/AN/AN/AN/A
Income ChangeN/A-45.96%-41.09%49.79%-94.63%549.32%

SAB Biotherapeutics, Inc. Warrant Annual Profit & Loss

All figures in USD

Particulars2021202320242025
Revenue$60.88M$2.24M$1.32M$0.00
Net Profit-$17.14M-$42.19M-$34.11M$13.27M
Net Profit Margin-28.16%-1884.50%-2579.03%N/A
Income ChangeN/A-146.11%19.17%138.92%

About SAB Biotherapeutics, Inc. Warrant

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

SAB Biotherapeutics, Inc. Warrant Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.02
$0.02
+112.50%
Jul 2026
$0.01
$0.01
-20.00%
Jun 2026
$0.01
$0.01
-79.17%
May 2026
$0.05
$0.05
+60.00%
Oct 2025
$0.04
$0.03
-25.00%
Jul 2025
$0.03
$0.04
+21.21%
Jun 2025
$0.03
$0.03
+6.45%
May 2025
$0.03
$0.03
+10.71%
Apr 2025
$0.03
$0.03
-17.65%
Mar 2025
$0.03
$0.03
+9.68%
Feb 2025
$0.04
$0.03
-13.89%
Jan 2025
$0.06
$0.04
-52.00%

SABSW Share Price FAQs

What is SAB Biotherapeutics, Inc. Warrant share price today?

chevron-up
SAB Biotherapeutics, Inc. Warrant share price today is $0.02 as on August 6, 2026 at 12:57 am IST.

What is the 52 week high and 52 week low of SAB Biotherapeutics, Inc. Warrant stock?

chevron-up
The 52 week high of SAB Biotherapeutics, Inc. Warrant stock is $0.05, while the 52 week low is $0.01 as of 6 Aug '26.

What is SABSW's market capitalisation today?

chevron-up
SABSW market capitalisation is $328300.57 as of August 10, 2026, at 8:16 am IST.

What is SABSW's net income for the last quarter?

chevron-up
SABSW's net income for the last quarter is 0.05B USD.

What is the 5 year returns of SABSW?

chevron-up
The 5 year returns of SABSW is -96.60% as on 6 Aug '26.

What is the high & low stock price of SABSW today?

chevron-up
SABSW stock price hit a high of $0.02 and low of $0.02 as of 6 Aug '26.

Can I buy SABSW shares in India?

chevron-up
Yes. You can buy SABSW in India by opening an international trading account.